Highmount Capital’s Zimmer Biomet ZBH Stock Holding History

Highmount Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$327K	Hold	3,087	–	–	0.08%	110
2015 Q1	$352K	Sell	3,087 -21	-0.7%	-$2.4K	0.09%	107
2014 Q4	$342K	Sell	3,108 -36	-1%	-$3.79K	0.08%	109
2014 Q3	$307K	Buy	3,144 +783	+33%	+$77K	0.08%	118
2014 Q2	$238K	Hold	2,361	–	–	0.06%	133
2014 Q1	$217K	Buy	+2,361	New	+$218K	0.05%	138

Other funds holding ZBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Highmount Capital's ZBH Position: Q2 2015 in Review

Highmount Capital held its Zimmer Biomet (ZBH) position steady in Q2 2015 at 3,087 shares worth $327K. The position accounts for 0.08% of the portfolio, ranked #110.

Highmount Capital first reported a position in ZBH in Q1 2014 and has held it in 6 quarters since. The position peaked at $352K in Q1 2015. 750 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Highmount Capital held 3,087 shares of Zimmer Biomet worth $327K as of Q2 2015.
Highmount Capital left its Zimmer Biomet share count unchanged in Q2 2015.
Zimmer Biomet made up 0.08% of Highmount Capital's portfolio in Q2 2015, its #110 holding.
Highmount Capital first reported a position in Zimmer Biomet in Q1 2014 and has held it in 6 quarters since.
Highmount Capital's Zimmer Biomet position peaked at $352K in Q1 2015.
750 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.